๐๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐๐ผ๐น๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป: ๐๐ฟ๐ผ๐บ ๐๐ฎ๐ฏ ๐๐ผ ๐๐น๐ถ๐ป๐ถ๐ฐ ๐๐ผ ๐๐ผ๐บ๐บ๐๐ป๐ถ๐๐: ๐ข๐๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐๐ฐ๐ฟ๐ผ๐๐ ๐๐ต๐ฒ ๐๐บ๐ฝ๐น๐ฒ๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ฆ๐ฝ๐ฒ๐ฐ๐๐ฟ๐๐บ
DETAILS
๐๐ฎ๐น๐น ๐ณ๐ผ๐ฟ ๐ฃ๐ฎ๐ฝ๐ฒ๐ฟ๐
๐๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐๐ผ๐น๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป: ๐๐ฟ๐ผ๐บ ๐๐ฎ๐ฏ ๐๐ผ ๐๐น๐ถ๐ป๐ถ๐ฐ ๐๐ผ ๐๐ผ๐บ๐บ๐๐ป๐ถ๐๐: ๐ข๐๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐๐ฐ๐ฟ๐ผ๐๐ ๐๐ต๐ฒ ๐๐บ๐ฝ๐น๐ฒ๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ฆ๐ฝ๐ฒ๐ฐ๐๐ฟ๐๐บ
๐๐ผ๐๐ฟ๐ป๐ฎ๐น:
Australian Journal of Psychology
๐ฃ๐๐ฏ๐น๐ถ๐๐ต๐ฒ๐ฟ:
Taylor & Francis Group
๐ ๐ฎ๐ป๐๐๐ฐ๐ฟ๐ถ๐ฝ๐ ๐๐ฒ๐ฎ๐ฑ๐น๐ถ๐ป๐ฒ:
01 July 2026
๐๐ฏ๐ผ๐๐ ๐๐ต๐ฒ ๐๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐๐ผ๐น๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป
The Australian Journal of Psychology invites submissions for its Article Collection titled From Lab to Clinic to Community: OCD Research Across the Implementation Spectrum. The collection aims to bridge the gap between theoretically driven experimental research on Obsessive-Compulsive Disorder (OCD) and its translation into clinical practice and community-based public health interventions.
Obsessive-Compulsive Disorder (OCD) is a disabling mental health condition affecting approximately 1โ2% of the global population. Characterised by intrusive thoughts and repetitive behaviours, OCD often emerges during adolescence and can result in substantial personal, familial, and societal burdens if left untreated. While evidence-based interventions, particularly cognitive-behavioural therapies, have significantly improved outcomes, barriers to diagnosis, treatment access, and implementation remain widespread globally.
This Article Collection seeks to promote interdisciplinary dialogue among researchers, clinicians, and public health practitioners by showcasing empirical studies that span the entire research continuumโfrom laboratory discoveries and translational science to clinical implementation and population-level mental health initiatives.
๐ง๐ผ๐ฝ๐ถ๐ฐ๐ ๐ผ๐ณ ๐๐ป๐๐ฒ๐ฟ๐ฒ๐๐
Submissions may address, but are not limited to, the following themes:
โข Psychological mechanisms underlying OCD across the developmental spectrum
โข OCD literacy and awareness initiatives
โข Moderators and predictors of OCD symptoms and treatment outcomes
โข Lived experiences of individuals with OCD
โข Laboratory findings with implications for OCD treatment and intervention design
โข Pilot studies of innovative therapeutic approaches for OCD
โข Implementation science research in healthcare settings
โข Population-based epidemiological studies and screening programmes
โข Digital health innovations and scalable interventions for OCD management
โข Healthcare policy and service delivery models for OCD care
โข Community-based prevention and early intervention strategies
โข Cross-cultural adaptation and implementation of evidence-based treatments
๐ช๐ต๐ ๐ง๐ต๐ถ๐ ๐๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐๐ผ๐น๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป ๐ ๐ฎ๐๐๐ฒ๐ฟ๐
Despite major advances in understanding and treating OCD, many individuals continue to experience delayed diagnosis, limited access to effective care, and inadequate treatment in community settings. By promoting research that explicitly connects laboratory findings with real-world implementation and public health practice, this collection aims to accelerate the translation of OCD science into meaningful improvements in patient outcomes and population mental health.
๐ฆ๐๐ฏ๐บ๐ถ๐๐๐ถ๐ผ๐ป ๐๐๐ถ๐ฑ๐ฒ๐น๐ถ๐ป๐ฒ๐
โข The collection welcomes empirical studies spanning scientific discovery, clinical applications, and population health impact.
โข Contributions from experimental, translational, clinical, and community-based research perspectives are encouraged.
โข All accepted articles will be published Open Access to ensure broad accessibility for researchers, clinicians, and public health stakeholders worldwide.
โข Queries regarding Open Access discount codes may be directed to Dr. MK Huffman at mary.huffman@taylorandfrancis.com.
๐๐ฟ๐๐ถ๐ฐ๐น๐ฒ ๐๐ผ๐น๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป ๐๐๐ฒ๐๐ ๐๐ฑ๐๐ถ๐๐ผ๐ฟ๐
โข Prof. Jessica R. Grisham, UNSW Sydney, Australia
โข Dr. Shiu Fung (Kelvin) Wong, Swinburne University of Technology, Australia
Posted on ServiceSetu Academics โ Premier Platform for Academic Opportunities & Research Collaboration
COMMENTS (0)
Sign in to join the conversation
SIGN IN TO COMMENT